A clear view of 30 stores, 52K+ orders, and 150K+ line items across 24 months — what's working, what's not, and where to act.
Here's what you need to know about Wellness Forever's performance across 30 stores over the past two years.
Across 30 stores, we brought in INR 78.67 Cr over 24 months — roughly INR 39.33 Cr per year. Revenue grew +11.0% year-over-year, and the average customer spends INR 16,318 per order.
Monthly trends, year-over-year growth, and which product categories are driving sales.
Revenue is on a steady upward path. We see a dip during monsoon months (Jun–Aug) and a spike around festive season (Oct–Nov) — that's expected. FY26 came in at INR 41.39 Cr, which is +11.0% higher than FY25. What to do: Plan inventory and staffing around seasonal patterns to capture even more of the festive demand.
A health check on our customer base: who's loyal, who needs attention, and who we're at risk of losing.
30.8% of our customers haven't placed an order in over 90 days. That puts INR 21.21 Cr in annual revenue at risk — money we could lose if we don't act. 1,538 customers need a reason to come back. What to do: Launch re-engagement campaigns (personalized offers, reminders) for at-risk customers before they're gone for good.
Champions (15.2%) and Loyal (18.9%) customers are the backbone of our revenue. Meanwhile, 9.5% "Need Attention" and 15.2% are "At Risk." What to do: Reward loyal customers to keep them engaged, and run targeted win-back offers for the at-risk group before they slip into the "Lost" category.
Which products drive the business, and where there's room to improve profitability.
Just 131 products out of 1,000 (13.1% of our catalog) bring in 80% of our revenue. If even a few of these go out of stock, the revenue impact is significant. Prescription medicines account for 48.9% of total sales. What to do: Ensure these top sellers never face stockouts. Set up automatic reorder alerts for the top 131 products.
Generic medicines earn a 18.7% margin vs 26.7% for branded. By strategically promoting generics where clinically appropriate, we can improve overall profitability without sacrificing quality. What to do: Train pharmacists to recommend generic alternatives, especially for high-volume branded products.
Performance by location, city, and store type — who's leading and who needs help.
Mumbai dominates both in store count and revenue. Flagship stores generate significantly more revenue per location, validating the larger format investment. But underperforming stores represent untapped potential. What to do: Study what top stores do differently (staffing, layout, product mix) and replicate those practices in lower-performing locations.
When products aren't on the shelf, customers walk away. Here's how often that's happening.
Our stockout rate is 6.1% — above the 5% target. Every empty shelf is a customer who might not come back. We estimate stockouts alone cost us INR 2.42 Cr in lost sales. What to do: Increase safety stock on the 15 most frequently out-of-stock products and set up automated reorder triggers.
Revenue we should have earned but lost to cancellations, returns, stockouts, and late deliveries.
Out of every 100 rupees in potential revenue, we lose 10.6 rupees before it reaches the bank. Here's where it goes:
What to do: Tackle cancellations first (highest impact). Identify the top 3 cancellation reasons and create action plans for each.
Are we keeping our delivery promise? How are customers choosing to pay? When do they shop?
We deliver on time 93.3% of the time, with an average delivery of just 1.1 days. Online sales make up 30.2% of revenue and trending upward. UPI is the most popular payment method, reflecting India's digital shift. What to do: Focus on the 6.7% of late deliveries — identify problem routes and peak-hour bottlenecks to push on-time delivery above 95%.